Pharmaceutical Technology, October 2012 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2012
Volume 36
Issue 10

Combination Drugs - Adding Up the Opportunities in Solid Dosage

External Link - article-806811.pdf

Articles in this issue
Pharmaceutical Technology, October 2012 Issue (PDF)
Integration of Less-Formal Risk Assessment Tools into Change Control
Integration of Less-Formal Risk Assessment Tools into Change Control
Technical Forum: Disposable Chromatography
Technical Forum: Disposable Chromatography
i8_t-791912-1408595509997.jpg
Uniformity of Dosage Units Using Large Sample Sizes
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
i1-791910-1408595518060.jpg
A World without R&D
Quality by Design for Analytical Methods: Implications for Method Validation and Transfer
Quality by Design for Analytical Methods: Implications for Method Validation and Transfer
Supplier Qualification
Supplier Qualification
Advancing Protein Crystallization: Microgravity Effects and Predictive Models
Determining Potency of Preclinical Dose Formulations
Determining Potency of Preclinical Dose Formulations
Report from India
Report from India
i1-791898-1408595560153.jpg
Tools in Waiting: Time for Evolutionary Operation
Outsourcing Pharmaceutical Infrastructure Operations
Outsourcing Pharmaceutical Infrastructure Operations
Case Closed
Obtaining Stable Homogenous Mixtures with Micronized APIs
Obtaining Stable Homogenous Mixtures with Micronized APIs
Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Gilead Treatment for PBC Granted EC Conditional Marketing Authorization

Patrick Lavery
February 21st 2025
Article

Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation by CHMP in December 2024.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Site Logo

Bio/Pharma Outsourcing Innovation eBook February 2025

February 21st 2025
Article
Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Google Launches AI Co-Scientist System

Susan Haigney
February 20th 2025
Article

The AI co-scientist is a multi-agent AI system that can work as a virtual scientific collaborator.

Site Logo

Robotics Implementation – A Study in Automation

Colbert Packaging
February 20th 2025
Article

In this case study, Colbert shares the methodology behind its robotic implementation, from defining the scope through vendor selection, design considerations and project wins.